Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].

Zhonghua yi xue za zhi - 7 Mar 2006

Guan Xi-zhou, Liu You-ning, Luo Yan-ping, She Dan-yang, Lu Si-jing, Zhou Guang, Chen Liang-an

Abstract excerpt

OBJECTIVE: To study the resistant phenotype of a clinical strain of Escherichia coli and to explore the effect of its attenuator mutation on AmpC expression. METHODS: A clinical strain of Escherichia coli 20022 (ECO20022) resistant to cefoxitin was isolated clinically. The phenotype was examined by three-dimensional methods, isoelectric focusing (IEF), and microdilution method. The regulator genes of ECO20022...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to beta-Lactamases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Drug Resistance, Multiple, Bacterial

Share to Escherichia coli

Share to Escherichia coli Infections

Share to Gene Expression Regulation, Bacterial

Share to Microbial Sensitivity Tests

Source

Identifiers

PMID: 16681904

Genes

CAT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].PMID 16681904Read ↗

Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR.Semantic proximity Read ↗

Transcriptional expression of secondary resistance genes ccdB and repA2 is enhanced in presence of cephalosporin and carbapenem in Escherichia coliSemantic proximity Read ↗

Identification of genotypes of plasmid-encoded AmpC beta-lactamases from clinical isolates and characterization of mutations in their promoter and attenuator regions.Semantic proximity Read ↗

High-Level Expression of AmpC β-Lactamase Due to Insertion of Nucleotides between −10 and −35 Promoter Sequences in Escherichia coli Clinical Isolates: Cases Not Responsive to Extended-Spectrum-Cephalosporin TreatmentSemantic proximity Read ↗

[The mutation and the selection of inactivating enzymes against antibiotic resistances].Semantic proximity Read ↗

ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.Semantic proximity Read ↗

AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strainsSemantic proximity Read ↗

Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae.Semantic proximity Read ↗

Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.Semantic proximity Read ↗

An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection.Semantic proximity Read ↗

[Stringent RNA polymerase of E. coli and its in vivo transcriptional activity].Semantic proximity Read ↗

Chloromycetin resistance of clinically isolated E coli is conversed by using EGS technique to repress the chloromycetin acetyl transferase.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.